03:53 PM EST, 11/21/2024 (MT Newswires) -- Iterum Therapeutics ( ITRM ) shares were up 9.2% in recent trading on Thursday after the company said it got written notice from the Nasdaq's Listing Qualifications Staff about regaining compliance with continued listing requirements.
Price: 1.78, Change: +0.15, Percent Change: +9.20